249
Views
2
CrossRef citations to date
0
Altmetric
Articles

Administration of a Nutraceutical Mixture Composed by Aloe arborescens, Annona muricata, Morinda citrifolia, Beta rubra, Scutellaria baicalensis, and Vaccinium myrtillus Reduces Doxorubicin-Induced Side Effects

, , , , , & ORCID Icon show all
Pages 343-351 | Received 17 Dec 2018, Accepted 20 May 2019, Published online: 01 Jul 2019

References

  • Minotti G, Menna P, Salvatorelli E, Cairo G, and Gianni L: Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56, 185–229, 2004. doi: 10.1124/pr.56.2.6
  • Wang J: DNA topoisomerases. Annu Rev Biochem 65, 635–692, 1996. doi: 10.1146/annurev.bi.65.070196.003223
  • Berthiaume J, and Wallace K: Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 23, 15–25, 2007. doi: 10.1007/s10565-006-0140-y
  • Carvalho F, Burgeiro A, Garcia R, Moreno A, and Carvalho R: Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev 34, 106–135, 2014. doi: 10.1002/med.21280
  • Zhang S, Liu X, Bawa-Khalfe T, Lu L, Lyu Y, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18, 1639–1642, 2012. doi: 10.1038/nm.2919
  • Fogli S, Nieri P, and Breschi M: The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J 18, 664–675, 2004. doi: 10.1096/fj.03-0724rev
  • Octavia Y, Tocchetti C, Gabrielson K, Janssens S, Crijns H, et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52, 1213–1225, 2012. doi: 10.1016/j.yjmcc.2012.03.006
  • Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, et al. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal 18, 899–929, 2013. doi: 10.1089/ars.2012.4795
  • Licata S, Saponiero A, Mordente A, and Minotti G: Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chem Res Toxicol 13, 414–420, 2000. doi: 10.1021/tx000013q
  • Carvalho C, Santos R, Cardoso S, Correia S, Oliveira P, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16, 3267–3285, 2009. doi: 10.2174/092986709788803312
  • Zolfagharzadeh F, and Roshan V: Pre-treatment Hepatoprotective Effect of Regular Aerobic Training Against Hepatic Toxicity Induced by Doxorubicin in rats. Asian Pac J Cancer Prev 14, 2931–2936, 2013. doi: 10.7314/APJCP.2013.14.5.2931
  • Zhang Q, Wang F, Jia K, and Kong L: Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects. Front Pharmacol 6, 1253, 2018.
  • Huang C, Ju D, Chang C, Muralidhar Reddy P, and Velmurugan B: A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei) 7, 23, 2017. doi: 10.1051/bmdcn/2017070423
  • Soeda M: Extract of Cape aloes inhibited sarcoma 180 and Ehrlich ascites tumours. J Med Soc Jpn 16, 365–369, 1969.
  • Hart LA, van Enckevort PH, van Dijk H, Zaat R, de Silva KT, and Labadie RP: Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. J Ethnopharmacol 23, 61–71, 1988. doi: 10.1016/0378-8741(88)90115-8
  • Winters WD, Benavides R, and Clouse WJ: Effects of aloe extracts on human normal and tumour cells in vitro. Econ Bot 35, 89–95, 1981. doi: 10.1007/BF02859219
  • Capasso F, Borrelli F, Capasso R, Di Carlo G, and Izzo A: Aloe and its therapeutic use. Phytother Res 12, 124–127, 1998.
  • Gavamukulya Y, Wamunyokoli F, and El-Shemy H: Annona muricata: is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med 10, 835–848, 2017. doi: 10.1016/j.apjtm.2017.08.009
  • Baskar R, Rajeswari V, and Kumar T: In vitro antioxidant studies in leaves of Annona species. Indian J Exp Biol 45, 480–485, 2007.
  • Liu C, Wu J, Gu J, Xiong Z, Wang F, et al. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav 86, 423–430, 2007. doi: 10.1016/j.pbb.2006.11.005
  • Sameer M, Sunil K, Ajay K, Surrinder K, Suri O, et al. A Review on Plants a useful source of anti-cancer drugs. J Pharm Res 4, 264–271, 2011.
  • Hwang Y, Jinhua M, Choi B, Cui C, Jeon W, et al. Effects of Scutellaria baicalensis on chronic cerebral hypoperfusion-induced memory impairments and chronic lipopolysaccharide infusion-induced memory impairments. J Ethnopharmacol 137, 681–689, 2011. doi: 10.1016/j.jep.2011.06.025
  • Luo H, Lv X, Wang G, Li Y, Kurihara H, et al. Anti-inflammatory effects of anthocyanins-rich extract from bilberry (Vaccinium myrtillus L.) on croton oil-induced ear edema and Propionibacterium acnes plus LPS-induced liver damage in mice. Int J Food Sci Nutr 65, 594–601, 2014. doi: 10.3109/09637486.2014.886184
  • Mohamad Shalan N, Mustapha N, and Mohamed S: Morinda citrifolia leaf enhanced performance by improving angiogenesis, mitochondrial biogenesis, antioxidant, anti-inflammatory & stress responses. Food Chem 212, 443–452, 2016. doi: 10.1016/j.foodchem.2016.05.179
  • Ninfali P, Antonini E, Frati A, and Scarpa E: C-Glycosyl flavonoids from Beta vulgaris Cicla and Betalains from Beta vulgaris rubra: Antioxidant, anticancer and antiinflammatory activities-A review. Phytother Res 31, 871–884, 2017. doi: 10.1002/ptr.5819
  • McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, and Wainwright CL: Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160, 1573–1576, 2010. doi: 10.1111/j.1476-5381.2010.00873.x
  • Gibson-Corley KN, Olivier AK, and Meyerholz DK: Principles for valid histopathologic scoring in research. Vet Pathol 50, 1007–1015, 2013. doi: 10.1177/0300985813485099
  • Keizer G, Pinedo M, Schuurhuis J, and Joenje H: Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 47, 219–231, 1990. doi: 10.1016/0163-7258(90)90088-J
  • Sayed-Ahmed M, Khattab M, Gad M, and Osman A: Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacol Toxicol 89, 140–144, 2001. doi: 10.1034/j.1600-0773.2001.d01-148.x
  • Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, et al. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107, 896–910, 2003. doi: 10.1161/01.CIR.0000048192.52098.DD

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.